Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2015

01.06.2015 | Original Article - Cancer Research

Influence of tumor volume on survival in patients with oral squamous cell carcinoma

verfasst von: Thomas Mücke, David A. Mitchell, Lucas M. Ritschl, Andrea Tannapfel, Klaus-Dietrich Wolff, Marco R. Kesting, Denys J. Loeffelbein, Anastasios Kanatas

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The TNM classification is used to assess cancers of the oral cavity, and advancements in imaging techniques have revealed clear variations in tumor volume at presentation. This study therefore aimed to clarify whether preoperative imaging, with exact measurements of the tumor, could affect post-surgery survival after controlling for demographic, clinical, and tumor characteristics.

Methods

We included 437 patients with histologically confirmed, stage T1–4, N1–3, M0, invasive squamous cell carcinoma of the tongue. Participants were assessed for recurrence every 3 months for the first 2 years, every 6 months for another 2 years, and annually thereafter; routine computed tomography was performed annually. Associations were determined using the Kaplan–Meier estimator, univariate log-rank test, and Cox proportional hazards regression models.

Results

The mean survival of all patients was 68.1 ± 48.2 months. The 2- and 5-year overall survival rates were 82.2 and 66.7 %, respectively. The mean primary tumor volume was 7.14 cm3 with a range of 1.3–24.21 cm3. The ROC curve and Youden Index analysis revealed that the optimal cutoff volume was between ≤5.9 and ≤18.3 cm3 for three different volume groups (p < 0.0001). Large tumor volume was associated with a significantly poorer overall survival (p < 0.0001).

Conclusions

Tumor volume was significantly associated with the overall survival of patients. This has both prognostic and reconstructive implications that will affect health-related quality of life. In addition, this will inform surgical planning and the allocation of resources.
Literatur
Zurück zum Zitat Brown L, Rieger JM, Harris J, Seikaly H (2010) A longitudinal study of functional outcomes after surgical resection and microvascular reconstruction for oral cancer: tongue mobility and swallowing function. J Oral Maxillofac Surg 68(11):2690–2700. doi:10.1016/j.joms.2010.05.004 CrossRefPubMed Brown L, Rieger JM, Harris J, Seikaly H (2010) A longitudinal study of functional outcomes after surgical resection and microvascular reconstruction for oral cancer: tongue mobility and swallowing function. J Oral Maxillofac Surg 68(11):2690–2700. doi:10.​1016/​j.​joms.​2010.​05.​004 CrossRefPubMed
Zurück zum Zitat Chang HW, Ling GS, Wei WI, Yuen AP (2004) Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 101(1):125–132CrossRefPubMed Chang HW, Ling GS, Wei WI, Yuen AP (2004) Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 101(1):125–132CrossRefPubMed
Zurück zum Zitat Cunningham MJ, Johnson JT, Myers EN, Schramm VL Jr, Thearle PB (1986) Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity. Am J Surg 152(4):361–366CrossRefPubMed Cunningham MJ, Johnson JT, Myers EN, Schramm VL Jr, Thearle PB (1986) Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity. Am J Surg 152(4):361–366CrossRefPubMed
Zurück zum Zitat Dorie MJ, Kallman RF, Cebulska-Wasilewska A (1991) Interleukin-1 modification of the effects of cyclophosphamide and fractionated irradiation. Int J Radiat Oncol Biol Phys 20(2):311–314CrossRefPubMed Dorie MJ, Kallman RF, Cebulska-Wasilewska A (1991) Interleukin-1 modification of the effects of cyclophosphamide and fractionated irradiation. Int J Radiat Oncol Biol Phys 20(2):311–314CrossRefPubMed
Zurück zum Zitat Expert Panel on Radiation O-H and Neck, Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ (2011) ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral oncology 47(7):554–559. doi:10.1016/j.oraloncology.2011.05.002 CrossRef Expert Panel on Radiation O-H and Neck, Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ (2011) ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral oncology 47(7):554–559. doi:10.​1016/​j.​oraloncology.​2011.​05.​002 CrossRef
Zurück zum Zitat Furukawa M, Dillon JK, Futran ND, Anzai Y (2013) The prevalence of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: Is CT good enough for nodal staging? Acta Radiol 55(5):570–578. doi:10.1177/0284185113499326 CrossRefPubMed Furukawa M, Dillon JK, Futran ND, Anzai Y (2013) The prevalence of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: Is CT good enough for nodal staging? Acta Radiol 55(5):570–578. doi:10.​1177/​0284185113499326​ CrossRefPubMed
Zurück zum Zitat Kreppel M, Dreiseidler T, Rothamel D, Eich HT, Drebber U, Zoller JE, Scheer M (2013) The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery. J cranio-maxillo-facial surgery 41(1):22–27. doi:10.1016/j.jcms.2012.05.005 CrossRef Kreppel M, Dreiseidler T, Rothamel D, Eich HT, Drebber U, Zoller JE, Scheer M (2013) The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery. J cranio-maxillo-facial surgery 41(1):22–27. doi:10.​1016/​j.​jcms.​2012.​05.​005 CrossRef
Zurück zum Zitat Lo WL, Kao SY, Chi LY, Wong YK, Chang RC (2003) Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 61(7):751–758CrossRefPubMed Lo WL, Kao SY, Chi LY, Wong YK, Chang RC (2003) Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 61(7):751–758CrossRefPubMed
Zurück zum Zitat Matsui Y, Ohno K, Yamashita Y, Takahashi K (2007) Factors influencing postoperative speech function of tongue cancer patients following reconstruction with fasciocutaneous/myocutaneous flaps—a multicenter study. Int J Oral Maxillofac Surg 36(7):601–609. doi:10.1016/j.ijom.2007.01.014 CrossRefPubMed Matsui Y, Ohno K, Yamashita Y, Takahashi K (2007) Factors influencing postoperative speech function of tongue cancer patients following reconstruction with fasciocutaneous/myocutaneous flaps—a multicenter study. Int J Oral Maxillofac Surg 36(7):601–609. doi:10.​1016/​j.​ijom.​2007.​01.​014 CrossRefPubMed
Zurück zum Zitat Mücke T, Wagenpfeil S, Kesting MR, Hölzle F, Wolff KD (2008) Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol 45:687–691CrossRefPubMed Mücke T, Wagenpfeil S, Kesting MR, Hölzle F, Wolff KD (2008) Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol 45:687–691CrossRefPubMed
Zurück zum Zitat Mücke T, Wagenpfeil S, Kesting MR, Hölzle F, Wolff KD (2009) Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol 45(8):687–691CrossRefPubMed Mücke T, Wagenpfeil S, Kesting MR, Hölzle F, Wolff KD (2009) Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol 45(8):687–691CrossRefPubMed
Zurück zum Zitat Mücke T, Wolff KD, Wagenpfeil S, Mitchell DA, Hölzle F (2010) Immediate microsurgical reconstruction after tumor ablation predicts survival among patients with head and neck carcinoma. Ann Surg Oncol 17(1):287–295. doi:10.1245/s10434-009-0758-0 CrossRefPubMed Mücke T, Wolff KD, Wagenpfeil S, Mitchell DA, Hölzle F (2010) Immediate microsurgical reconstruction after tumor ablation predicts survival among patients with head and neck carcinoma. Ann Surg Oncol 17(1):287–295. doi:10.​1245/​s10434-009-0758-0 CrossRefPubMed
Zurück zum Zitat Mücke T, Koschinski J, Wagenpfeil S, Wolff KD, Kanatas A, Mitchell DA, Deppe H, Kesting MR (2012) Functional outcome after different oncological interventions in head and neck cancer patients. J Cancer Res Clin Oncol 138(3):371–376. doi:10.1007/s00432-011-1106-x CrossRefPubMed Mücke T, Koschinski J, Wagenpfeil S, Wolff KD, Kanatas A, Mitchell DA, Deppe H, Kesting MR (2012) Functional outcome after different oncological interventions in head and neck cancer patients. J Cancer Res Clin Oncol 138(3):371–376. doi:10.​1007/​s00432-011-1106-x CrossRefPubMed
Zurück zum Zitat Noguchi M, Kido Y, Kubota H, Kinjo H, Kohama G (1999) Prognostic factors and relative risk for survival in N1–3 oral squamous cell carcinoma: a multivariate analysis using Cox’s hazard model. Br J Oral Maxillofac Surg 37(6):433–437. doi:10.1054/bjom.1999.0146 CrossRefPubMed Noguchi M, Kido Y, Kubota H, Kinjo H, Kohama G (1999) Prognostic factors and relative risk for survival in N1–3 oral squamous cell carcinoma: a multivariate analysis using Cox’s hazard model. Br J Oral Maxillofac Surg 37(6):433–437. doi:10.​1054/​bjom.​1999.​0146 CrossRefPubMed
Zurück zum Zitat Oliveira LR, Ribeiro-Silva A, Costa JP, Simoes AL, Matteo MA, Zucoloto S (2008) Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(5):685–695. doi:10.1016/j.tripleo.2008.07.002 CrossRefPubMed Oliveira LR, Ribeiro-Silva A, Costa JP, Simoes AL, Matteo MA, Zucoloto S (2008) Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(5):685–695. doi:10.​1016/​j.​tripleo.​2008.​07.​002 CrossRefPubMed
Zurück zum Zitat Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955CrossRefPubMed Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955CrossRefPubMed
Zurück zum Zitat Poulsen MG, Denham JW, Peters LJ, Lamb DS, Spry NA, Hindley A, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q (2001) A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60(2):113–122CrossRefPubMed Poulsen MG, Denham JW, Peters LJ, Lamb DS, Spry NA, Hindley A, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q (2001) A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60(2):113–122CrossRefPubMed
Zurück zum Zitat Sheahan P, O’Keane C, Sheahan JN, O’Dwyer TP (2003) Effect of tumour thickness and other factors on the risk of regional disease and treatment of the N0 neck in early oral squamous carcinoma. Clin Otolaryngol Allied Sci 28(5):461–471CrossRefPubMed Sheahan P, O’Keane C, Sheahan JN, O’Dwyer TP (2003) Effect of tumour thickness and other factors on the risk of regional disease and treatment of the N0 neck in early oral squamous carcinoma. Clin Otolaryngol Allied Sci 28(5):461–471CrossRefPubMed
Zurück zum Zitat Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C (2003) Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185(3):278–284CrossRefPubMed Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C (2003) Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185(3):278–284CrossRefPubMed
Zurück zum Zitat Vergez S, Moriniere S, Dubrulle F, Salaun PY, De Mones E, Bertolus C, Temam S, Chevalier D, Lagarde F, Schultz P, Ferrie JC, Badoual C, Lapeyre M, Righini C, Barry B, Tronche S, De Raucourt D, SFORL (2013) Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx) Part I: Locoregional extension assessment: 2012 SFORL guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 130(1):39–45. doi:10.1016/j.anorl.2012.09.004 CrossRefPubMed Vergez S, Moriniere S, Dubrulle F, Salaun PY, De Mones E, Bertolus C, Temam S, Chevalier D, Lagarde F, Schultz P, Ferrie JC, Badoual C, Lapeyre M, Righini C, Barry B, Tronche S, De Raucourt D, SFORL (2013) Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx) Part I: Locoregional extension assessment: 2012 SFORL guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 130(1):39–45. doi:10.​1016/​j.​anorl.​2012.​09.​004 CrossRefPubMed
Zurück zum Zitat Whitehurst JO, Droulias CA (1977) Surgical treatment of squamous cell carcinoma of the oral tongue: factors influencing survival. Arch Otolaryngol 103(4):212–215CrossRefPubMed Whitehurst JO, Droulias CA (1977) Surgical treatment of squamous cell carcinoma of the oral tongue: factors influencing survival. Arch Otolaryngol 103(4):212–215CrossRefPubMed
Metadaten
Titel
Influence of tumor volume on survival in patients with oral squamous cell carcinoma
verfasst von
Thomas Mücke
David A. Mitchell
Lucas M. Ritschl
Andrea Tannapfel
Klaus-Dietrich Wolff
Marco R. Kesting
Denys J. Loeffelbein
Anastasios Kanatas
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2015
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1881-2

Weitere Artikel der Ausgabe 6/2015

Journal of Cancer Research and Clinical Oncology 6/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.